Research and Markets: Global Cancer Profiling Market Report 2013 - 2018

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/fnrl94/cancertumor) has announced the addition of the "Global Cancer Profiling Market Report 2013 - 2018" report to their offering.

Cancer profiling is witnessing significant growth in the healthcare industry. It is poised to grow rapidly in a range of application areas, including biomarker discovery and prognosis. The global market is valued at $14.99 billion in 2013 and is expected to reach $35.03 billion by 2018.

A range of tests (Barium X-ray, Blood tests, Bone marrow, Cystoscopy, Lumbar puncture etc.) are used for diagnosing specific types of cancer. A host of different treatment options for cancer, including chemotherapy, hormone therapy, surgery, radiotherapy, bisphosphonates, bone marrow and stem cell transplants, and biological therapies are also available.

Despite the availability of different treatment options, profiling a tumor - that is, knowledge about a patient's cancer profile - may identify genomic alterations that will help the physician to guide the patient to a systemic therapy with a higher likelihood of success. This will rule out those that are unlikely to be successful, on an individual basis, thereby minimizing the trial and error process.

Key Topics Covered:

1 Introduction

2 Executive Summary

3 Tumor Profiling Technology Landscape

4 Tumor Profiling Research Portfolio

5 Value Chain Analysis

6 Market Landscape Analysis

7 Technology Adoption And Development Potential, By Geography

7.1 Geographic Adoption And Development Potential - Overview

7.2 North America

7.3 Europe

7.4 Asia

7.5 Rest Of The World (ROW)

8 Technology Investment Analysis

9 Competitive Landscape Analysis

9.1 Competitive Landscape Analysis

9.2 Key Acquisitions/Partnerships/Agreements/Collaborations (2010-2013)

9.3 Technologies Available For Licensing & Acquisition For Stakeholders

10 Patent Analysis

11 Analyst Insights And Recommendations

11.1 Key Insights On The Market

11.2 Strategic Recommendations

11.3 Open Opportunity Invitations In The Field For Business Development

12 Company Profiles

Companies Mentioned:

  • Agendia
  • Biotheranostics
  • Boreal Genomics
  • Caris Life Sciences
  • Genomic Health
  • Illumina
  • Life Technologies Corporation
  • Nanostring Technologies
  • Neogenomics Laboratories
  • Oncopath Laboratory
  • Oxford Gene Technology
  • Precision Therapeutics
  • Proteome Sciences
  • Rational Therapeutics
  • Ribomed Biotechnologies

For more information visit http://www.researchandmarkets.com/research/fnrl94/cancertumor

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Diagnostics

Sharing

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Diagnostics